Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vistagen Therapeutics (VTGN) Times Interest Earned (2016 - 2019)

Vistagen Therapeutics (VTGN) has disclosed Times Interest Earned for 8 consecutive years, with $3975.3 as the latest value for Q4 2019.

  • Quarterly Times Interest Earned rose 199.49% to $3975.3 in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $10427.7 through Sep 2020, up 325.87% year-over-year, with the annual reading at -$3069.5 for FY2019, 92.39% down from the prior year.
  • Times Interest Earned hit $3975.3 in Q4 2019 for Vistagen Therapeutics, up from $347.47 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $3975.3 in Q4 2019 to a low of -$8501.0 in Q1 2016.
  • Historically, Times Interest Earned has averaged -$1835.5 across 5 years, with a median of -$1664.7 in 2017.
  • Biggest five-year swings in Times Interest Earned: crashed 40614.44% in 2016 and later skyrocketed 199.49% in 2019.
  • Year by year, Times Interest Earned stood at -$714.0 in 2015, then plummeted by 269.33% to -$2637.0 in 2016, then surged by 45.62% to -$1434.0 in 2017, then tumbled by 178.64% to -$3995.7 in 2018, then skyrocketed by 199.49% to $3975.3 in 2019.
  • Business Quant data shows Times Interest Earned for VTGN at $3975.3 in Q4 2019, $347.47 in Q3 2019, and -$3995.7 in Q4 2018.